Cargando…

Serum free IgE guided dose reduction of omalizumab: a case report

BACKGROUND: Omalizumab is a human IgG1 antibody against IgE used as a therapy for sever asthmatic patients with asthma. According to the guidelines of the Global Initiative for Asthma, omalizumab is an add-on drug at treatment step 5 that is used for severe asthma patients who are allergic to perenn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gon, Yasuhiro, Ito, Reiko, Maruoka, Shuichiro, Mizumura, Kenji, Kozu, Yutaka, Hiranuma, Hisato, Iida, Yuko, Shikano, Sotaro, Hashimoto, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577842/ https://www.ncbi.nlm.nih.gov/pubmed/28861109 http://dx.doi.org/10.1186/s13223-017-0211-z

Ejemplares similares

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Increased extracellular vesicle miRNA-466 family in the bronchoalveolar lavage fluid as a precipitating factor of ARDS
por: Shikano, Sotaro, et al.
Publicado: (2019)

A Changing Anti-Neutrophil Cytoplasmic Antibody Profile in a Patient With a Diagnosis of Eosinophilic Granulomatosis With Polyangiitis
por: Jinno, Yusuke, et al.
Publicado: (2023)

DsRNA induction of microRNA-155 disrupt tight junction barrier by modulating claudins
por: Hiranuma, Hisato, et al.
Publicado: (2020)

Iron-Dependent Mitochondrial Dysfunction Contributes to the Pathogenesis of Pulmonary Fibrosis
por: Takahashi, Mai, et al.
Publicado: (2022)

Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane
por: Iida, Yuko, et al.
Publicado: (2021)

Autophagy, selective autophagy, and necroptosis in COPD
por: Mizumura, Kenji, et al.
Publicado: (2018)

Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)

Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
por: Pennington, Luke F., et al.
Publicado: (2016)

Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
por: Tajiri, Tomoko, et al.
Publicado: (2023)

Idiopathic Central Alveolar Hypoventilation wherein Sleep Disordered Breathing Was Considered Well-controlled by the Continuous Positive Airway Pressure Tracking System but Not Controlled by Polysomnography
por: Hoshi, Mamiko, et al.
Publicado: (2022)

Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020)

Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy
por: Kariyawasam, Harsha H, et al.
Publicado: (2020)

IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab
por: Maronese, Carlo Alberto, et al.
Publicado: (2023)

Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells
por: Chan, Marcia A, et al.
Publicado: (2013)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
por: Sandström, Thomas
Publicado: (2009)

Current and future applications of the anti-IgE antibody omalizumab
por: Incorvaia, Cristoforo, et al.
Publicado: (2008)

Protocadherin-1 is a glucocorticoid-responsive critical regulator of airway epithelial barrier function
por: Kozu, Yutaka, et al.
Publicado: (2015)

Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumab
por: Davies, Anna M., et al.
Publicado: (2017)

Cluster analysis identifies a pathophysiologically distinct subpopulation with increased serum leptin levels and severe obstructive sleep apnea
por: Kozu, Yutaka, et al.
Publicado: (2020)

A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma
por: D’Amato, Gennaro, et al.
Publicado: (2007)

Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc complex crystallization
por: Mitropoulou, Alkistis N., et al.
Publicado: (2020)

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
por: Humbert, Marc, et al.
Publicado: (2013)

Intranasal administration of allergen increases specific IgE whereas intranasal omalizumab does not increase serum IgE levels—A pilot study
por: Eckl‐Dorna, J., et al.
Publicado: (2017)

Platypnoea–orthodeoxia syndrome affects nocturnal oxygen desaturation: A case report
por: Hoshi, Mamiko, et al.
Publicado: (2023)

Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
por: D’Amato, Gennaro, et al.
Publicado: (2014)

Effects of Omalizumab on FcεRI and IgE Expression in Lesional Skin of Bullous Pemphigoid
por: Seyed Jafari, S. Morteza, et al.
Publicado: (2019)

The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
por: Gasser, Pascal, et al.
Publicado: (2020)

Our future: Experiencing the coronavirus disease 2019 (COVID-19) outbreak and pandemic
por: Hashimoto, Shu, et al.
Publicado: (2021)

Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms
por: Kuo, Be-Sheng, et al.
Publicado: (2022)

Serum IgE Induced Airway Smooth Muscle Cell Remodeling Is Independent of Allergens and Is Prevented by Omalizumab
por: Roth, Michael, et al.
Publicado: (2015)

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone
por: Uzun, Rusen, et al.
Publicado: (2016)

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer
por: Vultaggio, Alessandra, et al.
Publicado: (2021)

Omalizumab for STAT3 Hyper-IgE Syndromes in Adulthood: A Case Report and Literature Review
por: Lan, Jun, et al.
Publicado: (2022)

The Diagnosis of Exogenous Lipoid Pneumonia Caused by the Silent Aspiration of Vegetable Oil Using a Lipidomic Analysis
por: Shimizu, Tetsuo, et al.
Publicado: (2019)

Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab
por: Saavedra, Michael C, et al.
Publicado: (2011)

Rescue therapy for refractory status asthmaticus with updosed omalizumab adjusted for IgE level, body weight and effect
por: Slevogt, Hortense, et al.
Publicado: (2022)

IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies
por: Barrios, D. M., et al.
Publicado: (2021)

A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
por: Okude, Azusa, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_acq9okq6l0q761ibc9gk9uk5oh